Epstein–Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation
Year: 2016
Type: article
Abstract: Epstein-Barr virus (EBV) super-enhancers (ESEs) are essential for lymphoblastoid cell (LCL) growth and survival. Reanalyses of LCL global run-on sequencing (Gro-seq) data found abundant enhancer RNAs (eRNAs) being transcribed at ESEs. Inactivation of ESE components, EBV nuclear antigen 2 (EBNA2) and bromodomain-containing protein 4 (BRD4), significantly decreased eRNAs at ESEs -428 and -525 kb upstream of the MYC oncogene transcription start site (TSS). shRNA knockdown of the MYC -428 and -525 ESE eRNA caused LCL growth arrest and reduced cell growth. Furthermore, MYC ESE eRNA knockdown also significantly reduced MYC expression, ESE H3K27ac signals, and MYC ESEs looping to MYC TSS. These data indicate that ESE eRNAs strongly affect cell gene expression and enable LCL growth.
Institutions: Brigham and Women's Hospital, Harvard University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Awards: Platform technology for detection of cancer-associated viruses in HIV patients, Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation, Epstein-Barr Virus Nuclear Protein B Cell Growth Transformation, Epstein-Barr Virus LMP1-Mediated Oncogenecity, Genetic and Biochemical Studies of KSHV LANA, Targeting Epstein-Barr Virus Super-Enhancer, KSHV Latent Infection Replication
OpenAlex ID: W2556468356
